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INTRODUCTION
Liver transplant restores lives; however, rapid excess 
weight gain and related metabolic complications negatively 
impact long-term outcomes.1 Optimizing cardiometabolic 
health for solid organ transplant recipients is crucial for 
improving survival,1 but to date, clinic-based weight loss 
programs have generally appeared ineffective for liver 
transplant recipients (LTRs).2
Liver Transplantation
Background. Rapid excess weight gain and metabolic complications contribute to poor outcomes following liver trans-
plant care. Providing specialist lifestyle intervention with equitable access is a challenge for posttransplant service delivery. 
Methods. This study investigated the feasibility of a 12-wk telehealth delivered lifestyle intervention for liver transplant 
recipients (randomized controlled trial with a delayed intervention control group). The intervention included 14 group ses-
sions facilitated by nutrition and exercise specialists via video streaming telehealth and participants used their own devices. 
Feasibility was assessed across session attendance, the adequacy, acceptability, and confidence with the telehealth tech-
nology and adherence to diet (Mediterranean Diet Adherence Score). Secondary pooled analysis of effectiveness was deter-
mined from changes in quality of life and metabolic syndrome severity score. Results. Of the 35 participants randomized, 
dropout was 22.8% (n = 8) and overall session attendance rate was 60%. Confidence with and adequacy of home tech-
nology was rated high in 96% and 91% of sessions, respectively. Participants randomized to the intervention significantly 
improved Mediterranean Diet Adherence Score (2-point increase [95% confidence interval, 1.5-3.4] versus control 0 point 
change [95% confidence interval, –1.4 to 1.2]; P = 0.004). Intervention (within group) analysis found the intervention sig-
nificantly decreased the metabolic syndrome severity score (–0.4 [95% confidence interval, –0.6 to –0.1] P = 0.01), and 
improved mental health-related quality of life (2.5 [95% confidence interval, 0.4-4.6] P = 0.03). Conclusions. A cardio-
protective lifestyle intervention delivered via telehealth is feasible for liver transplant recipients and may improve access to 
specialist care to support metabolic health and wellness after transplant.
(Transplantation Direct 2021;7: e667; doi: 10.1097/TXD.0000000000001118. Published online 4 February, 2021.)
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The Queensland Liver Transplant Service services a vast 
geographical area, more than twice that of Texas. Telehealth 
options are an obvious means of delivering services to LTRs 
who live remotely from their transplant center,3 as well as 
offering greater flexibility for those unable to attend the hos-
pital because of work or other commitments. There is also 
evidence of the benefits of providing telemedicine options 
for outpatient care of complex conditions,4 as well as keen 
interest from LTRs themselves for this model of care,5 but the 
safety and acceptability of remote support for lifestyle inter-
vention remains untested.
There is substantial evidence that improving diet quality, in 
particular a Mediterranean dietary pattern, has cardioprotective 
benefits for chronic disease6; however, given the unique meta-
bolic disruption observed in LTRs,1 investigation of the benefits 
in this population remains warranted. Exercise capacity and 
muscle strength of LTRs are significantly lower than age- and 
sex-matched people without solid organ transplant.7-9 We have 
shown that although activities of daily living increase posttrans-
plant, LTRs are apprehensive about exercise safety,5 with vigor-
ous activity not initiated, even years after transplant.10 Although 
exercise capacity and body composition can be improved in 
LTRs with combined nutrition and exercise intervention,11 
these programs typically rely on frequent face-to-face contact 
to access specialist support, resulting in poor attendance5,11 and 
unintentionally perpetuating inequalities in healthcare access.
In view of the changing landscape of service delivery, the 
primary aim of this study was to assess the safety and feasibil-
ity of telehealth delivery of a 12-wk cardioprotective lifestyle 
intervention (Mediterranean-style eating pattern and exercise 
prescription). The secondary aim was to assess the prelimi-
nary effectiveness of the intervention (versus usual care) on 
metabolic syndrome, diet quality, fitness, and health-related 
quality of life.
STUDY DESIGN
This pilot study was a randomized controlled trial, with 
a delayed-intervention control group, conducted at a tertiary 
hospital in Brisbane, Australia, between September 2017 and 
April 2018 (LIFE study; Australia and New Zealand Clinical 
Trials Register: ACTRN12617001260314). The Metro South 
Health Human Research Ethics Committee approved the 
study (HREC/17/QPAH/208), and all participants provided 
written informed consent.
PARTICIPANTS
All eligible LTRs scheduled for a medical outpatient review 
during the recruitment period (September 2017–January 
2018) were sent a letter, followed by a telephone call, notify-
ing them of the study, and inviting them to participate. LTRs, 
who did not have scheduled appointments during the recruit-
ment period but resided locally (within a 100-km radius of the 
clinic), were similarly invited to attend an appointment with 
the investigators. The study was described as an opportunity 
to pilot a new telehealth service delivery model, not as a trial of 
a treatment related specifically to their personal health status. 
LTRs were eligible if they met the following inclusion criteria: 
>6 mo postliver transplant; expected survival >1 y; and with 
current access to a device with a camera or computer hard-
ware with internet access and a webcam. Exclusion criteria 
were: LTRs with dietary restrictions, where in Mediterranean-
style diet (MedDiet) is contraindicated; physical condition 
whereby exercise training would be inappropriate; deemed 
unsafe to participate by their hepatologist; or non-English 
speaking and unable to read English. Participants completed a 
health history questionnaire to screen for any cardiovascular 
or musculoskeletal conditions. Patient medical records were 
also reviewed, and any potential participant that had a con-
traindication to exercise training was referred to their trans-
plant specialist for a decision regarding inclusion/exclusion.
STUDY GROUPS
Following baseline data collection, participants were ran-
domized (2:1) to the intervention (MedDiet+E) or delayed 
intervention control (CON-DI) arm, using a computer-
generated randomization sequence (REDCap Research 
Management System), stratified for sex, by the trial coordi-
nator (research team blinded) (see Figure 1). Randomization 
ratio was designed to support greater number of participants 
being exposed to the intervention being assessed for feasibility.
Participants allocated to the intervention arm (MedDiet+E) 
received a 12-wk, telehealth group-based exercise, and dietary 
intervention. The intervention was informed by our previous 
telehealth coaching program,12 and consumer engagement.5 
All intervention sessions were delivered via synchronous 
videoconferencing streamed to participants remotely in real 
time, via a secure internet platform hosted by the tertiary 
health service (CISCO Tanberg C20, Advanced Encryption 
Standard-128). Participants received a workbook containing 
information on goal setting, the MedDiet, exercise training 
heart rate targets, resistance training exercises, and telehealth 
troubleshooting advice, along with a MedDiet recipe book and 
a “starter pack” of food products (Supplementary Material, 
SDC, http://links.lww.com/TXD/A309). Participants received 
an aerobic stepper (Kmart Australia Limited, Australia), 
resistance TheraBands (Weechee, China), and an exercise mat 
(Kmart Australia Limited, Australia).
Before the group-based telehealth sessions, partici-
pants completed individual telehealth assessments with an 
Accredited Practicing Dietitian (APD; approximately 45 min) 
and Accredited Exercise Physiologist (AEP; approximately 
60 min), which included screening for musculoskeletal limi-
tations.13 Following the individual sessions, participants 
received weekly group-based telehealth sessions alternating 
between APD-delivered diet education sessions (30–45 min, 
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6 sessions total) and AEP-delivered exercise training sessions 
(45–60 min, 8 sessions total). Over the 12-wk program, par-
ticipants received a maximum of 14 telehealth contacts. A 
variety of days and times were available for group sessions 
including an “after-hours” option. If participants were unable 
to attend an APD telehealth session, then a telephone review 
was offered; telephone sessions were not offered for missed 
AEP telehealth sessions. Participants received up to 3 text mes-
sages between telehealth sessions (opt in/out process based on 
participant preference) that provided diet and exercise con-
tent and motivational tips (Table S1, SDC, http://links.lww.
com/TXD/A309). Prerecorded online education content on a 
private YouTube channel, such as short videos with exercise 
tips, exercise sessions, and recipe demonstrations, for viewing 
outside of appointment times was available. Email reminders 
were sent with links to online content at various times during 
the program.
Participants were educated on MedDiet principles to 
improve diet quality (Supplementary Material, SDC, http://
links.lww.com/TXD/A309). No specific advice was pro-
vided on calorie restriction. Participants were recommended 
to increase their physical activity to a minimum of 150 min 
moderate-to-vigorous aerobic activity per week plus muscle 
strength training on 2 d per week, consistent with national 
guidelines14 (see Supplementary Material, SDC, http://links.
lww.com/TXD/A309). The group-based exercise sessions 
involved aerobic and resistance exercises using the equipment 
provided. The telehealth sessions allowed the AEP to monitor 
and modify exercises in real time allowing both participants 
and practitioners to provide immediate feedback. At the end 
of each session, participants received advice on achieving their 
exercise goals along with an individualized exercise prescrip-
tion to complete unsupervised until the next exercise session 
(see Supplementary Material, SDC, http://links.lww.com/
TXD/A309).
Participants randomized to the CON-DI arm received 
usual care over the first 12 wk, which included routine care 
from their treating physician(s). Structured allied health sup-
port is not usual care beyond 3-mo posttransplant. CON-DI 
participants received the same MedDiet+E telehealth program 
after completion of the week 12 data collection (see Figure 1).
OUTCOME MEASURES
Feasibility and Safety
A number of indicators were used to assess feasibility: 
recruitment rate (% of eligible patients;); APD and AEP 
sessions completed (%), retention rate (%) and reasons for 
attrition and missing data; staff-reported adequacy of tech-
nology (yes/no) at the completion of each session; partic-
ipant-rated confidence with using technology (1 “not at all 
confident” to 10 “very confident”) and adequacy of their tech-
nology (1 “not at all adequate” to 10 “completely adequate”) 
at the completion of each session. A participant was deemed 
“lost to follow-up,” if there was no response to 3 phone calls 
and 3 email requests from the research team to reschedule a 
missed appointment. Any adverse events that occurred dur-
ing telehealth sessions were recorded. Participants were asked 
to report their perception of safety while exercising at each 
session (patient reported; yes/no) and any previous adverse 
events between sessions were recorded.
Secondary Outcomes
Data on secondary outcomes were collected at baseline and 
12 wk (and at 24 wk in CON-DI arm) for dietary adherence, 
exercise capacity, quality of life, and metabolic syndrome.
Dietary adherence was assessed using the Mediterranean 
Diet Adherence Screener (MEDAS),15 with a possible score 
ranging from 0 to 14 points (higher scores indicate greater 
MedDiet adherence). LTRs are advised to avoid alcohol after 
liver transplant so although still included in the survey, a 
score of 0 was anticipated for the alcohol component of the 
score. A 2-point increase in MEDAS score was deemed clini-
cally significant.16 Proportion of participants meeting cutoff 
for each food group criteria in the MEDAS tool was deter-
mined before and after the intervention. In addition, to assess 
for any unintended consequences on dietary costs, the cost 
of dietary intake was estimated at each time point (methods 
and data in Supplementary Material, SDC, http://links.lww.
com/TXD/A309).
Exercise capacity was assessed using the 6-min walk test 
(6MWT).17 At baseline, the test was conducted on a 10-m 
track within an indoor corridor, following a standardized 
published protocol.17 A premeasured piece of string marked 
the 10-m track and turn around points. The trained clini-
cian used a lap counter and calculated the number of meters 
walked to the nearest 10 m. Participants practiced using the 
lap counter during the baseline test and were provided with 
the test script, string, lap counter, and stopwatch for repeat 
home testing.
Trained health professionals performed clinical and func-
tional assessments at the baseline face-to-face clinic appoint-
ment on all participants. During this appointment, participants 
were instructed on how to perform each assessment at home 
FIGURE 1. Study Schema: Face-to-face screening and assessments performed by health practitioners before randomization into either 
MedDiet+E (intervention) or CON-DI. Baseline telehealth monitored outcomes were then collected from both groups before 12-wk RCT phase, 
in which MedDiet+E received the telehealth delivered program and CON-DI received usual care. Both groups repeated telehealth monitored 
outcome measures at wk 12. CON-DI then went on to receive the telehealth intervention for 12 wk followed by another repeat telehealth 
monitored outcome assessment on completion. CON-DI, delayed intervention control; MedDiet+E, Mediterranean diet + exercise Intervention 
group; RCT, randomized controlled trial.
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and were provided with written instructions and links to 
online tutorials. Equipment to conduct all functional meas-
ures was provided. Self-measured baseline clinical and func-
tional assessments were requested to be undertaken by all 
participants at home, unsupervised, within 1 wk of baseline 
clinic assessment (Figure 1). Results were recorded and sent to 
investigators via email or verbally transcribed at the next tel-
ehealth appointment. Reliability of home-based assessments 
compared with clinician-measured assessments in this group 
have been previously reported.18 At week 12, all participants 
repeated self-measured clinical and functional assessments. 
CON-DI arm participants repeated home-based assessments 
again at week 24 (postintervention). At each time point, par-
ticipants received up to 3 phone call reminders to complete 
home-based assessments.
Clinician-assessed body weight (SECA scales Robusta 813, 
Hamburg, Germany) was recorded to the nearest 0.5 kg. 
Participants used their own personal scales for home-based 
weight assessment (various brands, not recorded). Waist cir-
cumference was measured midway between the lower rib mar-
gin and iliac crest, to the nearest 1 cm. Identical tape measures 
were provided to all participants. Height was measured (once 
only) with a wall-mounted stadiometer.19 Clinician-assessed 
systolic and diastolic blood pressure were performed seated 
(after at least 5 min resting) using Welch Allyn Cerner Vital 
Signs Monitor with an appropriate size cuff. An average of 3 
measures were taken and recorded to the nearest 1 mm Hg. 
Participants were instructed to either use home blood pres-
sure machines (if available) or attend a local pharmacy to 
have blood pressure performed by a pharmacist (various 
brands, not recorded). Home- or pharmacy-based blood 
pressure readings were taken twice on the same arm, with at 
least 1 min between readings after sitting quietly for a mini-
mum of 5 min. If a >5 mm Hg difference between the first 
and second reading was observed, a third measure was taken. 
Participants reported all BP results and investigators calcu-
lated the average. Blood samples were collected at partici-
pants’ local pathology center after an overnight fast (at least 
8 h). Participants returned to the same pathology center for 
each blood collection. A metabolic syndrome severity score 
(MetSSS) was calculated.20
Health-related quality of life was assessed using the 12-item 
Short Form Health Survey (SF-12v2).21 Summary physical 
(physical component score 12) and mental (mental compo-
nent score for SF-12v2) components were constructed using 
the standard SF-12 version 2,22 with a higher score indicated 
better quality of life.
Statistical Analysis
Data are presented as mean (SD) or median (interquartile 
range [IQR]) after assessing for normality. Demographic data, 
clinician-derived anthropometric, and blood pressure data 
and clinical characteristics of participants at baseline were 
compared between MedDiet+E and CON-DI arms. All sub-
sequent clinical data analyzed for the randomized controlled 
trial (RCT) and pooled (within intervention group) analysis 
included patient-derived prepost data. Between-group dif-
ferences in change scores at 12 wk were examined using 
ANCOVA adjusting for baseline value of the outcome.
As a secondary exploratory analysis, data from imme-
diately preintervention and immediately postintervention 
in the MedDiet+E (ie, baseline and wk 12) and CON-DI 
(ie, wk 12 and 24) arms were pooled to assess the clini-
cal impact of the intervention exposure in all participants. 
Within-group comparisons were conducted using paired 
t-tests or Wilcoxon signed rank tests. One outlier in the 
intervention group was removed for all waist circumference 
analyses (recorded as 31 cm decrease in waist circumference 
and deemed implausible). Linear regression was performed 
to identify predictors of change in dietary adherence. All 
analyses were intention-to-treat, in which missing data 
were imputed using last observation carried forward23 or 
the mean value where in baseline data was missing (9%). 
Statistical significance was reported where P < 0.05, and all 




Of the 131 LTRs eligible to participate, 35 (26%) enrolled 
in the study and were randomized to the intervention 
(MedDiet+E n = 23) or control (CON-DI n = 12) groups; rea-
sons for refusal are shown in Figure 2. Recruited participants 
were 21–70 y of ages and primarily male (71%), which was 
the representative of a typical Australian transplant popula-
tion.24 Participants were a median of 4 (IQR, 2–6) y posttrans-
plant, with 9 (26%) living in regional areas (>50 km from 
metropolitan transplant center). There were no clinical differ-
ences between study groups in baseline demographic, clinical, 
or anthropometric variables, except for total cholesterol and 
low-density lipoprotein cholesterol, which were ~25% lower 
in the control group (Table 1).
Attendance, Attrition, and Missing Data
Of the 35 participants randomized, 8 participants 
(22.9%) withdrew (n = 2) or were lost to follow-up (n = 6) 
during the RCT phase (Figure 2) after completing an average 
of 1 session each for nutrition and exercise. An additional 4 
CON-DI arm participants withdrew during their interven-
tion phase. The participants who completed the interven-
tion participated in an average of 4.3 ± 1.8 dietetics sessions 
(71% of the 6 intended) and 4.1 ± 2.2 exercise sessions (52% 
of the 8 intended). Overall, 21% of data for outcome meas-
ures was missing (22% for the MedDiet+E group and 18% 
for the CON-DI group). Most missing data were due to attri-
tion or participants not completing online questionnaires or 
tests at home with missing data for 9% of baseline clinician 
measures versus 30% of home-based follow-up measures. 
Based on type of measure, the highest proportions of miss-
ing data were for blood tests (29%), physical function tests 
(21%), and blood pressure measurements (17%), followed 
by anthropometry, MEDAS score, and quality of life score 
(each 15%).
Technology Access and Connectivity
Audio/visual “dropouts” or connection errors occurred in 
20% of sessions (44/212 sessions) but only ever impacted an 
individual within a group (where in the remainder of group 
remained unaffected) and was not related to connection type. 
Staff-reported technology was adequate for 90% of the ses-
sions. Participants rated ≥8  of  10 for their confidence level 
with home technology in 96% of the sessions and for ade-
quacy of the technology in 91% of sessions.
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Safety
Five participants (14%) required clearance from a trans-
plant specialist to commence exercise. One patient was deemed 
unsuitable for exercise because of uncontrolled hypertension. 
There were no study-related adverse events. No participant 
reported feeling unsafe while exercising.
Dietary Adherence
There was a greater improvement in the MEDAS in the 
MedDiet+E compared with CON-DI group (2.4 [1.5, 3.4] ver-
sus –0.1 [–1.4, 1.2], P = 0.004; Table 2) with mean adherence 
score reaching 7.7 ± 2.5 by end of study in the MedDiet+E 
group. Additionally, there was a greater proportion meeting 
at least a 2-point increase in score in the MedDiet+E group 
compared with CON-DI at 12 wk (14  of  23 [61%] versus 
1 of 12 [8%], P < 0.001). Cost analysis revealed the daily cost 
of dietary intake was not different from before to during the 




There was no difference between groups for change 
in anthropometry, clinical, or functional endpoints 
preintervention to postintervention (Table  2). A statistically 
and clinically meaningful improvement in the mental compo-
nent summary score in the MedDiet+E group (49.7 ± 9.2 to 
52.6 ± 7.9) versus the CON-DI group (50.5 ± 8.3 to 48.3 ± 9.1) 
was observed, whereas no differences were observed between 
groups for the physical component of quality of life.
Preintervention and Postintervention—Pooled Analysis
Table 3 summarizes the within-group intervention changes 
on clinical, biochemical, and functional outcomes. From pre-
intervention to postintervention, there was a significant reduc-
tion in waist circumference (–1.9 [IQR, –3.8 to –0.1] cm), body 
mass index (–0.5 [IQR, –0.8 to –0.1] kg/m2) and MetSSS (–0.4 
[IQR, –0.6 to –0.1]) and an improvement in mental component 
summary score (+2.5 [IQR, 0.4–4.6]). A significant improve-
ment was also observed in diet quality with an increase in 
the MEDAS score (6 points [IQR, 4–7] versus 8 points [IQR, 
6–10], P < 0.001; Figure 3), with 19 participants (54%) achiev-
ing a clinically significant increase of at least 2 points.
Linear regression analysis was performed to predict change 
in MEDAS based on demographic variables. Female gender 
significantly predicted change in MEDAS (F (1, 33) = 4.287; 
P = 0.046), but there were no significant relationships with 
age (P = 0.487) or time since transplant (P = 0.586). There was 
FIGURE 2. Consort diagram. CON-DI, delayed intervention control; MedDiet+E, Mediterranean-style diet + exercise intervention group.
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a significant positive correlation between change in MEDAS 
and attendance at dietary sessions (r = 0.478; P = 0.018). When 
examining the aspects of the MedDiet that changed in response 
to the intervention, more individuals achieved the criteria, 
compared with baseline, for the amount of olive oil (P = 0.001), 
fish (P = 0.039), commercial sweets/pastries (P = 0.008), nuts 
(P = 0.004), and Sofrito (P = 0.039) consumed (Figure 4).
DISCUSSION
In this pilot study, we demonstrated for the first time that 
a telehealth-delivered diet and exercise intervention is accept-
able and safe for LTRs and may effectively target cardiometa-
bolic risk factors and improve mental components of quality 
of life. LTRs enrolled in this study successfully used a range 
of personal technologies to video link with clinicians for indi-
vidualized and group sessions for diet and exercise support, 
and both LTRs and staff found telehealth delivery for diet and 
exercise a highly acceptable method of receiving care.
Telehealth attendance to group sessions was acceptable 
(50%–70%) albeit lower for exercise sessions compared with 
dietary sessions, and similar rates for telephone coaching pro-
grams tested in other conditions.12,25 An intervention with a simi-
lar style of remote exercise supervision achieved 83% attendance 
in a cardiac rehab setting.26 The lower attendance rate observed 
in this trial compares with other lifestyle interventions in LTRs, 
which have achieved only 15%–37% face-to-face attendance.11,27 
Although participants could dial in to a dietary session from 
practically any location (eg, at work, or while away on holidays), 
participating in an exercise session requires additional prepara-
tion around the practicalities of exercising such as appropriate 
location, clothing and footwear, and access to exercise equip-
ment. These barriers, common also for face-to-face exercise ses-
sions, remain relevant for telehealth exercise appointments.
The program focused on diet quality as a targeted cardio-
vascular risk factor. The relatively low MEDAS score at base-
line and lack of dietary pattern change in the control group 
indicates that, without specialized support, communities fol-
lowing a Western-style diet are unlikely to naturally adopt 
this cardioprotective dietary pattern after liver transplant. 
Diet quality improved after telehealth, similarly to other face-
to-face interventions in Australian cohorts28,29 with >50% of 
participants achieving ≥2-point increase in MEDAS score. 
TABLE 2.
Dietary, anthropometric, clinical and functional outcomes for control and MedDiet+E intervention groups
 
 
Control (n = 12) Intervention (n = 23) Control




BL vs wk 12
estimated marginal 









Mediterranean diet (MEDAS) 6.0 (2.1) 5.9 (3.2) 5.3 (1.4) 7.7 (2.5) –0.1 (–1.4, 1.2) 2.4 (1.5, 3.4) 0.004
Waist circumference (cm) 101 (18) 100 (18) 97 (14) 94 (12) –0.5 (–4.8, 3.7) –4.5 (–7.6, –1.5) 0.132
Weight (kg) 86.3 (21.4) 86.3 (21.6) 80.7 (18.1) 79.0 (17.3) 0.1 (–1.5, 1.7) –1.8 (–2.9, –0.6) 0.061
Body mass index (kg/m2) 28.6 (8.3) 28.6 (8.3) 27.5 (5.5) 26.8 (5.3) 0.0 (–0.5, 0.5) –0.6 (–1.0, 0–.3) 0.050
Systolic blood pressure (mm Hg) 134 (15) 131 (12) 131 (17) 128 (16) –2.3 (–9.2, 4.7) –2.8 (–7.8, 2.2) 0.901
Diastolic blood pressure (mm Hg) 84 (11) 83 (9) 82 (12) 81 (11) –0.9 (–4.3, 2.5) –0.9 (–3.3, 1.6) 0.985
Glucose (mmol/L) 5.9 (1.4) 5.5 (1.0) 5.4 (0.7) 5.4 (0.7) –2.4 (–0.7, 0.2) –0.1 (–0.4, 0.2) 0.491
Total cholesterol (mmol/L) 3.9 (1.1) 4.0 (1.0) 4.7 (0.8) 4.6 (0.8) –0.0 (–0.2, 0.1) –0.1 (–0.2, 0.0) 0.570
Triglycerides (mmol/L) 1.1 (0.5) 1.6 (1.6) 1.3 (0.9) 1.3 (0.7) 0.4 (–0.2, 1.0) 0.0 (–0.4, 0.4) 0.247
LDL (mmol/L) 2.1 (0.8) 2.1 (0.8) 2.9 (0.8) 2.8 (0.6) –0.2 (–0.4, 0.0) 0.0 (–0.1, 0.1) 0.124
HDL (mmol/L) 1.2 (0.3) 1.2 (0.3) 1.2 (0.5) 1.3 (0.4) 0.0 (–0.1, 0.1) 0.1 (–0.1, 0.1) 0.531
MetSSS 2.8 (2.3) 2.2 (2.3) 2.1 (1.8) 1.5 (1.7) –0.5 (–1.1, 0.0) –0.7 (–1.1, –0.3) 0.625
6-min walk test (m) 436 (83) 425 (71) 448 (139) 465 (125) –15 (–71, 41) 19 (–22, 60) 0.323
PCS-12 39.8 (7.5) 42.7 (8.4) 48.0 (8.1) 49.3 (8.0) 1.1 (–2.7, 5.0) 2.2 (–0.6, 4.9) 0.681
MCS-12 50.5 (8.3) 48.3 (9.1) 49.7 (9.2) 52.6 (7.9) –2.0 (–5.4, 1.4) 2.8 (0.3, 5.2) 0.026
Data are mean (SD) and estimated marginal means for change in endpoints.
Bolded P values represent statistical significance.
aComparison of change between groups using ANCOVA adjusting for baseline values.
BL, baseline; CI, confidence interval; HDL, high-density lipoprotein cholesterol.; LDL, low-density lipoprotein cholesterol; MCS-12, mental component score for SF12v2; MEDAS, Mediterranean Dietary 
Adherence Screener; MetSSS, metabolic syndrome severity score; PCS, physical component score.
TABLE 1.
Demographic, anthropometric and clinical characteristics 







Sex, male (%) 10 (83%) 15 (65%)
Age, y 50 (15) 51 (15)
Years since transplant 3 [1, 10] 4 (2, 6)
Weight, kg 87.0 (22.1) 81.0 (17.8)
Body mass index, kg/m2 29.2 (8.4) 27.6 (8.4)
Waist circumference, cm 102 (94) 97 (14)
Systolic blood pressure, mm Hg 138 (14) 133 (18)
Diastolic blood pressure, mm Hg 85 (9) 83 (10)
Glucose, mmol/L 6.0 (1.6) 5.4 (0.8)
Total cholesterol, mmol/L 3.8 (1.2) 4.9 (0.9)
Triglycerides, mmol/L 1.1 (0.5) 1.3 (1.0)
LDL cholesterol, mmol/L 2.1 (0.9) 3.0 (0.9)
HDL cholesterol, mmol/L 1.3 (0.4) 1.3 (0.4)
Data are mean (SD) for continuous variables or median [IQR] if not normally distributed. Data 
for clinician-measured weight, body mass index, waist circumference, and blood pressure are 
presented. Missing data for glucose (n = 7), total cholesterol (n = 9), triglycerides (n = 8), LDL 
cholesterol (n = 9), and HDL cholesterol (n = 9).
CON-DI, delayed intervention control; HDL, high-density lipoprotein cholesterol; IQR, interquar-
tile range; LDL, low-density lipoprotein cholesterol; MedDiet+E, Mediterranean diet + exercise 
Intervention group.
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Adopting a MedDiet outside of the Mediterranean region has 
its challenges,30-33 but with appropriate support, we found the 
MedDiet was an acceptable strategy to improve diet quality 
in an Australian liver transplant population.34 The acceptabil-
ity of the MedDiet pattern in Western societies and to what 
degree of adherence to “traditional” MedDiet principles is 
necessary for clinical effect is an ongoing scientific debate.35 
Nonetheless, with increasing clinical interest in shifting 
dietetic services to facilitate more cardioprotective diet pat-
terns in liver clinics,36 considerations of multicultural patient 
groups are a welcome development to better translate the evi-
dence for MedDiet effectiveness for those living outside of the 
Mediterranean.35,37,38 Importantly, this study indicated a shift 
to a greater Mediterranean style of eating could be done in a 
cost-neutral manner, reflecting the results of cost effectiveness 
evaluations in other Australian settings.39,40
Despite no specific advice regarding calorie restriction, after 
exposure to the intervention, participants experienced a reduc-
tion in body mass and waist circumference, as is consistent 
with other MedDiet trials.41,42 This improvement was the main 
factor driving the improvement of MetSSS in the pooled analy-
sis, along with a trend to improvements in serum triglyceride. 
This aligns with results from short term43,44 and larger, long-
term (>12 mo) studies of the MedDiet.31,45 In highly supported 
environments, an improvement in metabolic syndrome with 
adherence to MedDiet has been demonstrated for other solid 
organ transplant recipients.46 This study is the first to demon-
strate preliminary data for cardiometabolic benefit related to 
telehealth delivered dietary support for LTRs. In addition, a 
service such as this which engages consumers in the codesign,5 
highlights the value that health and social support can have on 
improving mental components of quality of life.47
In the absence of specific clinical guidelines for posttrans-
plant exercise prescription, the study targeted general health 
prescription14 and included bouts of moderate and vigorous-
intensity aerobic exercise and resistance exercises. The exer-
cise sessions with telehealth supervision were safe, with no 
adverse events in well-screened participants. This is consist-
ent with previous work showing specialist-prescribed exer-
cise is safe before48,49 and after transplant.11,27,50,51 Although 
in-person supervised exercise can lead to significant improve-
ments in fitness and global strength with low dropout, it has 
been shown that a significant proportion of patients (45% in 
a recent study) are unable to participate because they live too 
far away from their transplant center.52 This study provides 
support for greater investment in telehealth care, particularly 
in settings like Australia, where centralized specialist services 
have vast geographical outreach.
The study recruitment rate of 25% was similar to other 
studies of transplant recipients where in  telephone recruit-
ment was linked with upcoming clinic visits50 and was repre-
sentative of the typical demographics of the transplant service. 
However, a greater uptake may be desired if rolled out into 
TABLE 3.
Intervention (within group) analysis of anthropometric, clinical and functional outcomes preintervention and postinter-
vention (n = 35)
 Preintervention Postintervention Mean difference (95% CI) Pa
Waist circumference (cm) 98.0 (15.0) 96.2 (14.7) –1.9 (–3.8, –0.1) 0.032
Weight (kg) 82.6 (19.3) 81.2 (19.2) –1.3 (–2.3, –0.3) 0.011
Body mass index (kg/m2) 27.8 (6.5) 27.3 (6.6) –0.5 (–0.8, –0.1) 0.009
Systolic blood pressure (mm Hg)b 131 (15) 129 (15) –1.8 (–5.5, 1.8) 0.311
Diastolic blood pressure (mm Hg)b 82 (11) 81 (10.0) –1.6 (–3.7, 0.6) 0.150
Glucose 5.4 (0.8) 5.4 (0.8) 0.0 (–0.2, 0.1) 0.833
Total cholesterol (mmol/L)b 4.5 (1.0) 4.5 (1.0) 0.0 (–0.2, 0.1) 0.642
Triglycerides (mmol/L) 1.4 (1.2) 1.2 (1.2) –0.2 (–0.4, 0.0) 0.056
LDL (mmol/L)b 2.6 (0.8) 2.6 (0.8) 0.0 (–0.2, 0.1) 0.814
HDL (mmol/L) 1.2 (0.4) 1.3 (0.4) 0.0 (0.0, 0.1) 0.735
MetSSS 2.2 (1.9) 1.8 (1.9) –0.4 (–0.6, –0.1) 0.014
6-min walk test (m)b 440 (119) 463 (108) 23 (–17, 62) 0.248
PCS-12 46.6 (8.4) 48.1 (7.4) 1.5 (–0.6, 3.5) 0.135
MCS-12 49.8 (8.6) 52.3 (7.6) 2.5 (0.4, 4.6) 0.028
Data are mean (SD) for the intention-to-treat population.
Bolded P values represent statistical significance.
aPre and postintervention compared using Wilcoxon signed rank test for most variables ^.
bData was normally distributed and dependent t-tests were used.
CI, confidence interval; HDL, high-density lipoprotein cholesterol.; LDL, low-density lipoprotein cholesterol; MCS-12, mental component score for SF12v2; MetSSS, metabolic syndrome severity score; 
PCS, physical component score.
FIGURE 3. Mediterranean Diet Adherence Screener (MEDAS) scores 
(out of possible 14) preintervention and postintervention (n = 35) 
**P < 0.001, Wilcoxon signed rank test.
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usual care. Time since transplant may impact recruitment as 
Krasnoff et al11 achieved almost twice the recruitment rate 
when they invited patients within 2 mo of transplant. LTRs 
from our center have indicated they want support early after 
transplant,5 and this may prevent excess weight gain within 
the first 6 mo posttransplant.10 This feasibility study was 
offered to patients as a pilot of new service delivery, rather 
than a direct personal care need. It is likely that uptake may be 
greater if eligible LTR are offered to link with telehealth ser-
vice before hospital discharge. Studies of diet and exercise for 
weight reduction are typically burdened with dropout rates of 
20%–40% due to high demands on time and behavior changes 
of participants.53,54 Across the limited number of studies that 
have tested diet and exercise interventions in LTRs, all within 
supervised clinical settings, dropout rates have ranged between 
25% and 40%.11,55 It was an important observation for feasi-
bility assessment that dropout rates of this study were similar 
or better than for those interventions delivered face to face.
Relying on remote monitoring of outcomes is an ongoing 
dilemma for telehealth services. In this study, missing data were 
mostly related to participants not completing or reporting their 
home-based assessments within the required time frame. This was 
despite online data entry, alleviating the need for postage or clinic 
attendance. Investing in partnerships with LTRs and highlighting 
the value of their participatory role in their posttransplant care 
is a cultural shift that may improve confidence and participation 
in self-monitoring. Modest financial incentives have been shown 
to facilitate health behavior changes such as increased walking 
in solid organ transplant recipients, and although this is not a 
traditional strategy, it is an example of how to improve LTRs 
engagement with health monitoring and reporting.50
Other lessons from this study were that adequate orienta-
tion of patients to the technology was crucial to ensure confi-
dence and literacy in an unsupervised setting, as was training 
of clinical staff to troubleshoot technical connection issues in 
real time. This requires diversion of some staff time to tech-
nology-related tasks. Modeling has indicated that although 
eHealth delivery modes for dietetic intervention have a cost to 
establish, the recurring costs are lower than face-to-face care.56 
In addition, qualitative analysis from participants indicated 
that the cost savings to patients through reduced travel time 
and lost work hours associated with face-to-face appointments 
were highly valued.34 Experience with rapid disruptions to tel-
ehealth delivery of care during the COVID-19 pandemic57 is 
likely to drive demand for this transition for many services.
A strength of this study is the LTR codesign of the interven-
tion.5 We were able to demonstrate clinical benefit with greater 
convenience and no perceptible increase in cost for LTRs, with-
out sacrificing the rapport and trust that comes from engaging 
with a specialist center.34 Inclusion of LTRs from regional and 
metropolitan areas captured the feasibility of telehealth con-
nections across a range of locations. Recent experiences with 
Covid-19 disruptions to service delivery reflected the experi-
ence of this study whereby the cost of or access to technol-
ogy is rarely a barrier to engaging with telehealth, however 
reliable and strong internet connection can at times be an 
issue for rural communities in Australia. Although the study 
participants were broadly representative of our typical patient 
cohort, results may not be generalizable to other transplant 
centers. Participants were not severely metabolically impaired 
at baseline, and metabolic outcomes were only evaluated short 
term. Although metabolic benefit of the Mediterranean diet has 
been demonstrated within 12 wk in other studies,43,44 larger, 
long-term studies in more specific populations, are needed to 
adequately address the potential metabolic confounders on 
clinical complications such as steroid use, nutritional status, 
and excess weight gain early posttransplant. Implementation 
processes that assist uptake of services in the peritransplant 
phase, before patients returning to competing life commit-
ments, may be beneficial to enhance adoption.
CONCLUSION
Telehealth delivery of diet and exercise facilitated sessions 
that target cardiometabolic risk factors in LTRs is safe and 
feasible; however, remote outcome monitoring remains a 
challenge for some patients. Using technology to disrupt tra-
ditional service delivery models may improve access of care 
and may be one strategy for supporting metabolic health and 
wellness of LTRs.
FIGURE 4. Proportion of participants meeting the criteria for individual Mediterranean Diet Adherence Screener components (n = 35) *P < 0.05; 
**P < 0.01. To achieve a score for each question, participants were required to (1) use olive oil as the main source of fat for cooking, (2) include 
≥4 tablespoons of olive oil a d, (3) include ≥2 servings of vegetables a d, (4) include ≥3 pieces of fruit per d, (5) include <1 serve of red meat 
or sausages per d, (6) include <1 serve butter/cream per d, (7) include <100 mL of sugar-sweetened beverages per d, (8) include ≥3 serves 
of legumes/pulses per wk, (9) include ≥3 serves of fish or shellfish per wk, (10) include <3 commercial sweets/pastries per wk, (11) include ≥3 
serves of nuts a wk, (12) preferentially consume chicken, turkey, or rabbit instead of veal, pork, hamburger, or sausage, and (13) prepare ≥2 or 
more meals per wk seasoned with sofrito (sauce of tomatoes and onion, garlic, or leek, sautéed in olive oil).
© 2021 The Author(s). Published by Wolters Kluwer Health, Inc. Hickman et al 9
ACKNOWLEDGMENTS
Thank you to  Nicholas Matigian from the MetroSouth 
Biostatistics Clinic; Sean O’Halloran from the Princess 
Alexandra Hospital UQ Telehealth Centre; patients and staff 
of the Queensland Liver Transplant Service; and  Victoria 
Williams, Ilaria Croci, and Keira Murray who assisted data 
collection and data entry. Thank you to companies who 
donated food product and equipment for the participant 
“starter packs” including Cobram Estate Olive Oil, Almond 
Board of Australia, Heinz Australia, Safcol, Simplot Australia, 
Woolworths (Buranda), and Diabetes Queensland.
REFERENCES
 1. European Association for the Study of the Liver. EASL clinical practice 
guidelines: liver transplantation. J Hepatol. 2016;64:433–485.
 2. Patel SS, Siddiqui MB, Chadrakumaran A, et al. Office-based weight 
loss counseling is ineffective in liver transplant recipients. Dig Dis Sci. 
2020;65:639–646.
 3. Leimig R, Gower G, Thompson DA, et al. Infection, rejection, and hos-
pitalizations in transplant recipients using telehealth. Prog Transplant. 
2008;18:97–102.
 4. Flodgren G, Rachas A, Farmer AJ, et al. Interactive telemedicine: 
effects on professional practice and health care outcomes. Cochrane 
Database Syst Rev. 2015;2015:CD002098.
 5. Hickman IJ, Coran D, Wallen MP, et al. ‘Back to life’-using knowledge 
exchange processes to enhance lifestyle interventions for liver trans-
plant recipients: a qualitative study. Nutr Diet. 2019;76:399–406.
 6. Dinu M, Pagliai G, Casini A, et al. Mediterranean diet and multiple 
health outcomes: an umbrella review of meta-analyses of observa-
tional studies and randomised trials. Eur J Clin Nutr. 2018;72:30–43.
 7. De Bona M, Ponton P, Ermani M, et al. The impact of liver disease 
and medical complications on quality of life and psychological distress 
before and after liver transplantation. J Hepatol. 2000;33:609–615.
 8. Lemyze M, Dharancy S, Nevière R, et al. Aerobic capacity in patients 
with chronic liver disease: very modest effect of liver transplantation. 
Presse Med. 2010;39:e174–e181.
 9. Ratcliffe J, Longworth L, Young T, et al; Cost-Effectiveness of Liver 
Transplantation Team. Assessing health-related quality of life pre- 
and post-liver transplantation: a prospective multicenter study. Liver 
Transpl. 2002;8:263–270.
 10. McCoy SM, Campbell KL, Lassemillante AM, et al. Changes in dietary 
patterns and body composition within 12 months of liver transplanta-
tion. Hepatobiliary Surg Nutr. 2017;6:317–326.
 11. Krasnoff JB, Vintro AQ, Ascher NL, et al. A randomized trial of exer-
cise and dietary counseling after liver transplantation. Am J Transplant. 
2006;6:1896–1905.
 12. Whelan ME, Goode AD, Eakin EG, et al. Feasibility, effectiveness and 
cost-effectiveness of a telephone-based weight loss program delivered 
via a hospital outpatient setting. Transl Behav Med. 2016;6:386–395.
 13. Thompson PD, Arena R, Riebe D, et al; American College of Sports 
Medicine. ACSM’s new preparticipation health screening recommen-
dations from ACSM’s guidelines for exercise testing and prescription, 
ninth edition. Curr Sports Med Rep. 2013;12:215–217.
 14. Brown WJ, Bauman AE, Bull FC, et al. Development of evidence-
based physical activity recommendations for adults (18-64 years). 
Report prepared for the Australian Government Department of 
Health; 2012. Available at https://www1.health.gov.au/internet/main/
publishing.nsf/Content/health-pubhlth-strateg-phys-act-guidelines. 
Accessed July 1, 2020.
 15. Papadaki A, Johnson L, Toumpakari Z, et al. Validation of the English 
version of the 14-item mediterranean diet adherence screener of the 
PREDIMED study, in people at high cardiovascular risk in the UK. 
Nutrients. 2018;10:138.
 16. Martínez-González MA, García-Arellano A, Toledo E, et al. A 14-item 
Mediterranean diet assessment tool and obesity indexes among high-
risk subjects: the PREDIMED trial. PLoS One. 2012;7:e43134.
 17. Coombes J, Skinner T. ESSA’s Student Manual for Health, Exercise 
and Sport Assessment. Elsevier Health Sciences; 2014.
 18. Keating SE, Barnett A, Croci I, et al. Agreement and reliability of cli-
nician-in-clinic versus patient-at-home clinical and functional assess-
ments: implications for telehealth services. Arch Rehabil Res Clin 
Transl. 2020;2:100066.
 19. International Society for the Advancement of Kinanthropometry. 
International Standards for Anthropometric Assessment. International 
Society for the Advancement of Kinanthropometry; 2001.
 20. Wiley JF, Carrington MJ. A metabolic syndrome severity score: 
a tool to quantify cardio-metabolic risk factors. Prev Med. 
2016;88:189–195.
 21. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: 
construction of scales and preliminary tests of reliability and validity. 
Med Care. 1996;34:220–233.
 22. Jayasinghe UW, Harris MF, Taggart J, et al. Gender differences in 
health-related quality of life of Australian chronically-ill adults: patient 
and physician characteristics do matter. Health Qual Life Outcomes. 
2013;11:102.
 23. Liu-Seifert H, Zhang S, D’Souza D, et al. A closer look at the base-
line-observation-carried-forward (BOCF). Patient Prefer Adherence. 
2010;4:11–16.
 24. Australia and New Zealand Liver and Intestinal Transplant Registry. 
ANZLITR 30th Annual Report 2020. 2020. Available at https://www3.
anzltr.org/. Accessed July 1, 2020.
 25. Viglione C, Bouwman D, Rahman N, et al. A technology-assisted 
health coaching intervention vs. enhanced usual care for primary care-
based obesity treatment: a randomized controlled trial. BMC Obes. 
2019;6:4.
 26. Hwang R, Bruning J, Morris NR, et al. Home-based telerehabilitation 
is not inferior to a centre-based program in patients with chronic heart 
failure: a randomised trial. J Physiother. 2017;63:101–107.
 27. Totti V, Tamè M, Burra P, et al. Physical condition, glycemia, 
liver function, and quality of life in liver transplant recipients after 
a 12-month supervised exercise program. Transplant Proc. 
2019;51:2952–2957.
 28. Mayr HL, Tierney AC, Kucianski T, et al. Australian patients with coro-
nary heart disease achieve high adherence to 6-month Mediterranean 
diet intervention: preliminary results of the AUSMED Heart Trial. 
Nutrition. 2019;61:21–31.
 29. Davis C, Hodgson J, Bryan J, et al. Older Australians can achieve high 
adherence to the Mediterranean diet during a 6 month randomised 
intervention; results from the Medley Study. Nutrients. 2017;9:534.
 30. Haigh L, Bremner S, Houghton D, et al. Barriers and facilita-
tors to Mediterranean diet adoption by patients with nonalcoholic 
fatty liver disease in Northern Europe. Clin Gastroenterol Hepatol. 
2019;17:1364–1371.e3.
 31. Echeverría G, Dussaillant C, McGee EE, et al. Promoting and imple-
menting the Mediterranean diet in the southern hemisphere: the 
Chilean experience. Eur J Clin Nutr. 2019;72(Suppl 1):38–46.
 32. Thodis A, Itsiopoulos C, Kouris-Blazos A, et al. Observational study 
of adherence to a traditional Mediterranean diet, sociocultural char-
acteristics and cardiovascular disease risk factors of older Greek 
Australians from MEDiterranean ISlands (MEDIS-Australia Study): pro-
tocol and rationale. Nutr Diet. 2018;75:44–51.
 33. Jacobs DR Jr, Petersen KS, Svendsen K, et al. Considerations 
to facilitate a US study that replicates PREDIMED. Metabolism. 
2018;85:361–367.
 34. Barnett A, Campbell KL, Mayr HL, et al. Liver transplant recipients’ 
experiences and perspectives of a telehealth-delivered lifestyle pro-
gramme: a qualitative study. J Telemed Telecare. [Epub ahead of print. 
January 27, 2020]. doi:10.1177/1357633X19900459.
 35. Martínez-González MÁ, Hershey MS, Zazpe I, et al. Transferability of 
the Mediterranean diet to non-Mediterranean countries. What is and 
what is not the Mediterranean diet. Nutrients. 2017;9:1226.
 36. Murray E, McCoy S, Campbell K, et al. Modern day challenges for 
the nutrition management of liver transplant recipients. Nutr Diet. 
2014;71:86–91.
 37. Radd-Vagenas S, Fiatarone Singh MA, Daniel K, et al. Validity of the 
Mediterranean diet and culinary index (MediCul) for online assessment 
of adherence to the ‘traditional’ diet and aspects of cuisine in older 
adults. Nutrients. 2018;10:1913.
 38. Knight A, Bryan J, Murphy K. Is the Mediterranean diet a feasible 
approach to preserving cognitive function and reducing risk of demen-
tia for older adults in Western countries? New insights and future 
directions. Ageing Res Rev. 2016;25:85–101.
 39. Segal L, Twizeyemariya A, Zarnowiecki D, et al. Cost effectiveness and 
cost-utility analysis of a group-based diet intervention for treating major 
depression - the HELFIMED trial. Nutr Neurosci. 2020;23:770–778.
 40. Chatterton ML, Mihalopoulos C, O’Neil A, et al. Economic evalu-
ation of a dietary intervention for adults with major depression (the 
“SMILES” trial). BMC Public Health. 2018;18:599.
10 Transplantation DIRECT   ■   2021 www.transplantationdirect.com
 41. Esposito K, Kastorini CM, Panagiotakos DB, et al. Mediterranean diet 
and weight loss: meta-analysis of randomized controlled trials. Metab 
Syndr Relat Disord. 2011;9:1–12.
 42. Bendall CL, Mayr HL, Opie RS, et al. Central obesity and the 
Mediterranean diet: a systematic review of intervention trials. Crit Rev 
Food Sci Nutr. 2018;58:3070–3084.
 43. Estruch R, Martínez-González MA, Corella D, et al; PREDIMED Study 
Investigators. Effects of a Mediterranean-style diet on cardiovascular 
risk factors: a randomized trial. Ann Intern Med. 2006;145:1–11.
 44. Properzi C, O’Sullivan TA, Sherriff JL, et al. Ad libitum Mediterranean 
and low-fat diets both significantly reduce hepatic steatosis: a 
Randomized Controlled Trial. Hepatology. 2018;68:1741–1754.
 45. Babio N, Toledo E, Estruch R, et al; PREDIMED Study Investigators. 
Mediterranean diets and metabolic syndrome status in the PREDIMED 
randomized trial. CMAJ. 2014;186:E649–E657.
 46. Entwistle TR, Green AC, Fildes JE, et al. Adherence to Mediterranean 
and low-fat diets among heart and lung transplant recipients: a rand-
omized feasibility study. Nutr J. 2018;17:22.
 47. Entwistle VA, Cribb A, Owens J. Why health and social care support 
for people with long-term conditions should be oriented towards ena-
bling them to live well. Health Care Anal. 2018;26:48–65.
 48. Williams FR, Vallance A, Faulkner T, et al. Home-based exercise in 
patients awaiting liver transplantation: a Feasibility Study. Liver Transpl. 
2019;25:995–1006.
 49. Wallen MP, Keating SE, Hall A, et al. Exercise training is safe and 
feasible in patients awaiting liver transplantation: a Pilot Randomized 
Controlled Trial. Liver Transpl. 2019;25:1576–1580.
 50. Serper M, Barankay I, Chadha S, et al. A randomized, controlled, 
behavioral intervention to promote walking after abdominal organ trans-
plantation: results from the LIFT study. Transpl Int. 2020;33:632–643.
 51. Beyer N, Aadahl M, Strange B, et al. Improved physical perfor-
mance after orthotopic liver transplantation. Liver Transpl Surg. 
1999;5:301–309.
 52. Moya-Nájera D, Moya-Herraiz Á, Compte-Torrero L, et al. Combined 
resistance and endurance training at a moderate-to-high inten-
sity improves physical condition and quality of life in liver transplant 
patients. Liver Transpl. 2017;23:1273–1281.
 53. Huys N, Van Stappen V, Shadid S, et al; Feel4Diabetes-study group. 
Effectiveness of a family-, school- and community-based interven-
tion on physical activity and its correlates in Belgian families with an 
increased risk for type 2 diabetes mellitus: the Feel4Diabetes-study. 
BMC Public Health. 2020;20:1231.
 54. Di Noia J, Schultz S, Monica D. Recruitment and retention of WIC 
participants in a longitudinal dietary intervention trial. Contemp Clin 
Trials Commun. 2019;16:100438.
 55. Totti V, Campione T, Mosconi G, et al. Promotion of pre- and post-
transplant physical exercise in the Emilia-Romagna region: the net-
work of the program “Transplantation, Physical Activity, and Sport”. 
Transplant Proc. 2019;51:2902–2905.
 56. Rollo ME, Burrows T, Vincze LJ, et al. Cost evaluation of providing 
evidence-based dietetic services for weight management in adults: 
In-person versus eHealth delivery. Nutr Diet. 2018;75:35–43.
 57. Webster P. Virtual health care in the era of COVID-19. Lancet. 
2020;395:1180–1181.
